Ignite Creation Date:
2024-05-05 @ 10:00 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01008098
Status:
UNKNOWN
Last Update Posted:
2012-06-07
First Post:
2009-11-03
Brief Title:
NeuroprotectiveNeurotrophic Effect of Lexapro in Patients With Posttraumatic Stress Disorder
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Study Overview
Official Title:
NeuroprotectiveNeurotrophic Effect of Lexapro in Patients With Posttraumatic Stress Disorder
Status:
UNKNOWN
Status Verified Date:
2012-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objectives of the current study are
1 to evaluate the efficacy of escitalopram in treatment for post-traumatic stress disorder
2 to find the structural changes of brain using magnetic resonance imaging and its association with the symptoms reduction and
3 to look at the differences of brain imaging findings and symptoms changes according to genetic differences of brain-derived neurotrophic factor a biological molecule facilitating neuronal growth in human
1 to evaluate the efficacy of escitalopram in treatment for post-traumatic stress disorder
2 to find the structural changes of brain using magnetic resonance imaging and its association with the symptoms reduction and
3 to look at the differences of brain imaging findings and symptoms changes according to genetic differences of brain-derived neurotrophic factor a biological molecule facilitating neuronal growth in human
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None